| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.33 | 0.05 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |